BGB-11417-203
Recruiting
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
BeOne Study ID 
BGB-11417-203
ClinicalTrials.gov ID
EudraCT Number
2023-503235-18-00
China Drug Trials ID
CTR20232718
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents